3Javaheri PA,Nekolaichuk C,Haennel E,et al.Feasibility of a pedometer- based walking pro6ram for survivors of breast and head and neck cancer undergoing radiation therapy[J].Physieth 6 rapie Canada,2015,67(2):205- 213.
4McNeely ML,Parliament MB,Seikaly H,et al.Sustainability of outcomes after a randomized crossover trial of resistance exercise for shoulder dysfunction in survivors of head and neck cancer[J].Physioth~rapieCanada,, 2015,67(1 ): 85-93.
5Thomas TO,P~efaat T,Choi M,et aI.Brachial plexus dose tolerance in head and neck cancer patients treated with 9equential intensity modulated radiation therapy[J]. Radiation oneology (London, England), 2015, 10(1 ): 94.
6Scanion C8,Banerjee g,fngiehart EC,et al.Galanin modulates the neural niche to favour perineurai invasion in head and neck cancer[J].Nature communications, 2015,6(2):6885.
7Hall SF,Irish JC,Gregg EW,et al.Adherence to and uptake of clinical practice guidelines:lessons learned from a clinical practice guideline on chemotherapy concomitant with radiotherapy in head-and-neck cancer[J]. Current oncology (Toronto, Ont.), 2015,22(2):e61-e68.
8Summerer I,Niyazi M,Unger K,et al.Erratum:Ohanges in circulating microF~NAs after radiochemotherapy in head and neck cancer patients[J]. R, adiation oncology (London, England), 2015,10(1 ): 102.
98achdev S,Refaat T,Bacchus ID,et aI.Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients[J].Radiation oncology (London, England), 201 5, 1 O(1 ): 93.
